BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3496391)

  • 1. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.
    Haeffner-Cavaillon N; Cavaillon JM; Laude M; Kazatchkine MD
    J Immunol; 1987 Aug; 139(3):794-9. PubMed ID: 3496391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of induction of IL-1 production in human monocytes by complement fragments.
    Arend WP; Massoni RJ; Niemann MA; Giclas PC
    J Immunol; 1989 Jan; 142(1):173-8. PubMed ID: 2783323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg).
    Fischer WH; Jagels MA; Hugli TE
    J Immunol; 1999 Jan; 162(1):453-9. PubMed ID: 9886419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes.
    Bacle F; Haeffner-Cavaillon N; Laude M; Couturier C; Kazatchkine MD
    J Immunol; 1990 Jan; 144(1):147-52. PubMed ID: 2136879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis.
    Takabayashi T; Vannier E; Clark BD; Margolis NH; Dinarello CA; Burke JF; Gelfand JA
    J Immunol; 1996 May; 156(9):3455-60. PubMed ID: 8617973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages.
    Cavaillon JM; Fitting C; Haeffner-Cavaillon N
    Eur J Immunol; 1990 Feb; 20(2):253-7. PubMed ID: 1690130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
    Warner SJ; Auger KR; Libby P
    J Immunol; 1987 Sep; 139(6):1911-7. PubMed ID: 3497983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylatoxins inhibit C2 production.
    Lappin D; Damerau B; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes.
    Weiss L; Haeffner-Cavaillon N; Laude M; Cavaillon JM; Kazatchkine MD
    Eur J Immunol; 1989 Jul; 19(7):1347-50. PubMed ID: 2668014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
    Hartung HP; Bitter-Suermann D; Hadding U
    J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipopolysaccharide-induced monocyte interleukin 1 secretion by gangliosides.
    Cavaillon JM; Fitting C
    Eur J Immunol; 1986 Aug; 16(8):1009-12. PubMed ID: 3527721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.
    Okusawa S; Dinarello CA; Yancey KB; Endres S; Lawley TJ; Frank MM; Burke JF; Gelfand JA
    J Immunol; 1987 Oct; 139(8):2635-40. PubMed ID: 3116090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and release of IL-1 beta by human peripheral blood monocytes in response to diverse stimuli: possible role of "microdamage" to account for unregulated release.
    Jessop JJ; Hoffman T
    Lymphokine Cytokine Res; 1993 Feb; 12(1):51-8. PubMed ID: 8457632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
    Kreuzpaintner G; Damerau B; Zimmermann B; Plummer TH; Brade V
    J Immunol; 1986 May; 136(9):3384-9. PubMed ID: 3485689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.
    Arend WP; Joslin FG; Massoni RJ
    J Immunol; 1985 Jun; 134(6):3868-75. PubMed ID: 2985700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.